PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
-6.81%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$2.56B
AUM Growth
+$2.56B
(-1.1%)
Cap. Flow
+$231M
Cap. Flow
% of AUM
9.01%
Top 10 Holdings %
Top 10 Hldgs %
34.93%
Holding
85
New
16
Increased
21
Reduced
12
Closed
9
Top Buys
| 1 |
Merck
MRK
|
$88.6M |
| 2 |
Axsome Therapeutics
AXSM
|
$52.1M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$50M |
| 4 |
Veeva Systems
VEEV
|
$40.1M |
| 5 |
argenx
ARGX
|
$39.7M |
Top Sells
| 1 |
Outset Medical
OM
|
$128M |
| 2 |
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
|
$34.1M |
| 3 |
Syndax Pharmaceuticals
SNDX
|
$28.1M |
| 4 |
Heron Therapeutics
HRTX
|
$20.1M |
| 5 |
HCA Healthcare
HCA
|
$20.1M |
Sector Composition
| 1 | Healthcare | 95.76% |
| 2 | Financials | 0.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
JNCE
51
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $12M | 0.46% | 3,949,668 -23,200 | -0.6% | -$70.3K |
|
52
Procept Biorobotics
PRCT
$2.23B
| $11.7M | 0.45% | +357,492 | New | +$11.7M |
|
|
53
Syndax Pharmaceuticals
SNDX
$1.41B
| $11.2M | 0.43% | 580,768 -1,462,609 | -72% | -$28.1M |
|
54
iTeos Therapeutics
ITOS
| $11.1M | 0.42% | +537,954 | New | +$11.1M |
|
|
OSH
55
DELISTED
Oak Street Health, Inc.
OSH
| $10.2M | 0.39% | 618,761 +95,117 | +18% | +$1.56M |
|
56
IO Biotech
IOBT
$104M
| $10.1M | 0.38% | 2,159,155 +797,011 | +59% | +$3.72M |
|
57
Prothena Corp
PRTA
$441M
| $9.37M | 0.36% | +345,114 | New | +$9.37M |
|
|
ISEE
58
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $8.72M | 0.33% | 906,016 -99,200 | -10% | -$954K |
|
59
Intellia Therapeutics
NTLA
$1.22B
| $8.45M | 0.32% | 163,280 -124,629 | -43% | -$6.45M |
|
60
Praxis Precision Medicines
PRAX
$958M
| $8.08M | 0.31% | 3,297,347 +2,432,528 | +281% | +$5.96M |
|
61
Editas Medicine
EDIT
$231M
| $7.45M | 0.28% | +629,684 | New | +$7.45M |
|
62
Werewolf Therapeutics
HOWL
$59.9M
| $7.08M | 0.27% | 1,730,723 +1,145,396 | +196% | +$4.68M |
|
63
Sight Sciences
SGHT
$213M
| $6.98M | 0.27% | +776,281 | New | +$6.98M |
|
64
SOPHiA GENETICS
SOPH
$234M
| $6.39M | 0.24% | 1,766,062 -247,962 | -12% | -$898K |
|
65
Sana Biotechnology
SANA
$777M
| $6.13M | 0.23% | 952,733 +597,461 | +168% | +$3.84M |
|
66
Acadia Pharmaceuticals
ACAD
$4.38B
| $5.43M | 0.21% | +384,995 | New | +$5.43M |
|
|
AERI
67
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $5.25M | 0.2% | 699,531 -389,035 | -36% | -$2.92M |
|
|
BLSA
68
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
| $4.6M | 0.18% | 464,103 | – | – |
|
|
JYAC
69
DELISTED
Jiya Acquisition Corp. Class A Common Stock
JYAC
| $4.59M | 0.17% | 464,103 | – | – |
|
|
CMPS
70
Compass Pathways
CMPS
$424M
| $4.25M | 0.16% | +392,764 | New | +$4.25M |
|
71
ESSA Pharma
EPIX
$11.4M
| $3.03M | 0.12% | +961,716 | New | +$3.03M |
|
|
PRDS
72
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
| $2.46M | 0.09% | 801,204 +70,847 | +10% | +$218K |
|
73
Biogen
BIIB
$19.4B
| – | – | 0 | – | – |
|
74
C4 Therapeutics
CCCC
$185M
| – | – | -284,772 | Closed | -$6.91M |
|
75
DexCom
DXCM
$29.5B
| – | – | -37,021 | Closed | -$18.9M |
|